Abstract

The immune response against malignant tumors is performed through multiple immune cell types; each of them has been shown to be effective in its antitumor activity; this has inspired many therapeutic approaches such as adoptive cells transfers or stimulation through antitumoral antibodies or cytokines. The present opinion article is approaching the immune response in cancer from a holistic perspective, exploring the possibility that it may be used in integrated approaches, in cancer immunotherapy.

Keywords:Lymphocyte; Cancer; Integrated; Immunotherapy; Interle

Abbreviations:LT-Lymphocyte; NK-Natural Killer Lymphocyte; CD-Cluster of Differentiation; TH-T Helper Lymphocyte; PD-L1-Programmed-Death Receptor Ligand-1